# Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients

> **NCT07483671** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Chengdu Syncor Pharmaceutical Co., Ltd.** · enrollment: 80 (estimated)

## Conditions studied

- Bacterial Vaginosis

## Interventions

- **DRUG:** BPR-101 capsules:Investigational product for the treatment of BV
- **OTHER:** Placebo：matching the investigational product in appearance, dosage form, and route of administration

## Key facts

- **NCT ID:** NCT07483671
- **Lead sponsor:** Chengdu Syncor Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2027-01-24
- **Final completion:** 2027-01-24
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07483671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07483671, "Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07483671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*